Sanjay Shukla
Chief Executive Officer chez ATYR PHARMA, INC.
Fortune : 227 269 $ au 31/03/2024
Profil
Dr. Sanjay S.
Shukla, MD, is a President, Chief Executive Officer & Director at aTyr Pharma, Inc. He is on the Board of Directors at aTyr Pharma, Inc. Dr. Shukla was previously employed as a Vice President & Head-Integrated Medical Services by Novartis AG and a Chief Executive Officer by Rxmd, Inc. He received his undergraduate degree from the University of Maryland, a graduate degree from the University of Maryland and a doctorate degree from Howard University College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATYR PHARMA, INC.
0,17% | 01/03/2024 | 116 548 ( 0,17% ) | 227 269 $ | 31/03/2024 |
Postes actifs de Sanjay Shukla
| Sociétés | Poste | Début |
|---|---|---|
| ATYR PHARMA, INC. | Chief Executive Officer | 01/11/2017 |
Anciens postes connus de Sanjay Shukla
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/04/2015 |
| Rxmd, Inc. | Chief Executive Officer | 01/09/2012 |
Formation de Sanjay Shukla
| University of Maryland | Graduate Degree |
| Howard University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Rxmd, Inc. |
